THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)

• 收藏
• 分享

专利权人:

Bayer Pharma Aktiengesellschaft

发明人:

Claudia HIRTH-DIETRICH,Peter SANDNER,Johannes-Peter STASCH,Michael HAHN,Markus FOLLMANN,Alexandros VAKALOPOULOS

申请号：

US15571105

公开号：

US20180169095A1

申请日:

2016.05.02

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Use of sGC stimulators, sGC activators alone, or in combination with PDE5 inhibitors for the prevention and healing of Digital Ulcers which are concomitant to fibrotic diseases, such as systemic sclerosis and scleroderma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/